Morgan Stanley raised the firm’s price target on Aramark (ARMK) to $42 from $40 and keeps an Equal Weight rating on the shares. Organic growth “underwhelmed again” in Q2, but management noted increasing momentum through the quarter and maintained fiscal year guidance, which investors had worried was at risk, the analyst says in a post-earnings note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARMK:
